1252 related articles for article (PubMed ID: 32547323)
21. Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.
Qin ZJ; Liu L; Sun Q; Li X; Luo JF; Liu JS; Liu D
Medicine (Baltimore); 2020 Aug; 99(35):e21700. PubMed ID: 32871887
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the clinical characteristics of 77 COVID-19 deaths.
Wang K; Qiu Z; Liu J; Fan T; Liu C; Tian P; Wang Y; Ni Z; Zhang S; Luo J; Liu D; Li W
Sci Rep; 2020 Oct; 10(1):16384. PubMed ID: 33009426
[TBL] [Abstract][Full Text] [Related]
24. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.
Dong X; Sun L; Li Y
Int J Med Sci; 2020; 17(14):2225-2231. PubMed ID: 32922185
[No Abstract] [Full Text] [Related]
26. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
27. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
[TBL] [Abstract][Full Text] [Related]
28. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China.
Xu JB; Xu C; Zhang RB; Wu M; Pan CK; Li XJ; Wang Q; Zeng FF; Zhu S
Sci Rep; 2020 Sep; 10(1):15058. PubMed ID: 32929124
[TBL] [Abstract][Full Text] [Related]
29. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
[TBL] [Abstract][Full Text] [Related]
30. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
[TBL] [Abstract][Full Text] [Related]
32. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
[TBL] [Abstract][Full Text] [Related]
33. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
[TBL] [Abstract][Full Text] [Related]
34. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.
Zhao Y; Yin L; Patel J; Tang L; Huang Y
J Med Virol; 2021 Jul; 93(7):4358-4369. PubMed ID: 33739452
[TBL] [Abstract][Full Text] [Related]
35. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
[No Abstract] [Full Text] [Related]
36. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
Li Y; Han X; Alwalid O; Cui Y; Cao Y; Liu J; Gu J; Wang L; Fan Y; Shi H
Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
[TBL] [Abstract][Full Text] [Related]
37. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and predictive value of hypocalcemia in severe COVID-19 patients.
Liu J; Han P; Wu J; Gong J; Tian D
J Infect Public Health; 2020 Sep; 13(9):1224-1228. PubMed ID: 32622796
[TBL] [Abstract][Full Text] [Related]
39. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
40. Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.
Hu J; Zhou J; Dong F; Tan J; Wang S; Li Z; Zhang X; Zhang H; Ming J; Huang T
Medicine (Baltimore); 2020 Oct; 99(42):e22774. PubMed ID: 33080747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
